Potassium Chloride Powder

A clearly labeled 494 mg of potassium bicarbonate provides a meaningful, alkalizing alternative to the original's potassium contribution. The simple powder improves dose clarity, but impaired kidney function or potassium-retaining medicines can make the amount unsafe without guidance.

Potassium citrate supplies a meaningful 448 mg amount in a well-absorbed, alkalizing form. Its focused label gives stronger form and dose clarity than many mixed products, while kidney impairment and potassium-retaining medicines can raise blood potassium too far.

A named Albion amino acid complex provides a clearly identified potassium form for users who prefer a low-dose capsule. The 99 mg amount is far smaller than the higher-dose powder options, so its advantage is form clarity rather than substantial electrolyte delivery.

It is not below the original's already low recurring cost, so it serves as a close-value substitute rather than a strictly cheaper option. A clearly quantified 365 mg of potassium chloride makes this a focused, low-cost substitute for the original's potassium component. Chloride supports electrolyte replacement but lacks the buffering role of citrate or bicarbonate, and kidney impairment or potassium-retaining medicines can make supplementation unsafe.

It is not below the original's already low recurring cost, so it serves as a close-value substitute rather than a strictly cheaper option. Aspartate, citrate, and gluconate provide several usable potassium forms at accessible recurring value. The repeated 99 mg source entries make the total less clear, and the serving still appears intended for modest supplementation.

It is not below the original's already low recurring cost, so it serves as a close-value substitute rather than a strictly cheaper option. A 99 mg potassium amino acid complex offers a low-cost, deliberately modest alternative to the original. The amount contributes little beside daily dietary needs, so it fits limited supplementation rather than substantial electrolyte replacement.

A simple capsule supplies 200 mg of potassium citrate, providing an absorbable and alkalizing form at a moderate amount. It offers a practical middle ground between low-dose tablets and concentrated powders, with the same kidney and medication cautions that apply to added potassium.

A focused powder supplies 175 mg of potassium gluconate with excellent recurring value. The amount is more useful than a basic 99 mg tablet but remains a limited contribution beside dietary needs, and potassium retention from kidney disease or medicines still matters.

Citrate and an amino acid chelate provide useful form quality in a streamlined supplement. Repeated 99 mg entries make the total potassium amount ambiguous, but the low recurring cost supports cautious, modest use.